EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and prognostic significance of high-endothelial venule density in regional lymph nodes of esophageal adenocarcinoma

Aryan Mirzaie-Kuzehgarani, Tillmann Bedau, Johanna Teloh-Benger, Thomas Zander, Hans Anton Schlößer, Reinhard Büttner, Christiane Bruns, Alexander Quaas

Frontiers in Oncology · 14.07.2026 · 16

DOI: 10.3389/fonc.2026.1802849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 14.07.2026. Verfasst von Aryan Mirzaie-Kuzehgarani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal adenocarcinoma (EAC) is associated with poor prognosis despite advances in multimodal treatment. High endothelial venules (HEVs) facilitate lymphocyte trafficking and are linked to anti-tumor immunity. While HEVs have shown prognostic relevance in esophageal squamous cell carcinoma and gastric cancer, their role in regional lymph nodes of EAC patients remains unclear.

Methods

This retrospective study included 199 patients with EAC who underwent Ivor-Lewis esophagectomy between 2013 and 2021. Patients received perioperative chemotherapy (FLOT), neoadjuvant chemoradiotherapy (CROSS), or primary surgery. Tumor-free regional lymph nodes were immunohistochemically stained using the MECA-79 antibody to detect HEVs. Whole-slide images were digitally analyzed to quantify HEV density. Associations with clinicopathological parameters, treatment modality, therapy response, and survival outcomes were assessed. An exploratory analysis was performed in an additional cohort of 58 patients receiving adjuvant nivolumab therapy.

Results

HEVs were detectable in regional lymph nodes across all treatment groups. HEV density was significantly higher in patients older than 60 years compared to younger patients (p = 0.001) and was independent of treatment modality, pathological response, T-stage, and N-stage. No association was observed between HEV density and response to neoadjuvant therapy. Dichotomization into MECA-low and MECA-high groups confirmed age as the primary determinant of HEV density classification. Kaplan–Meier analyses showed no significant differences in overall or progression-free survival between MECA-low and MECA-high patients in the primary cohort. In the adjuvant nivolumab cohort, MECA-high patients demonstrated a non-significant trend toward improved two-year overall survival (90% vs. 67%).

Conclusions

HEV density in tumor-free regional lymph nodes of EAC patients is primarily age-dependent and independent of tumor stage, treatment response, and neoadjuvant therapy regimen. Although HEV density alone does not predict survival, observed trends in immunotherapy-treated patients suggest a potential modulatory role in immune responsiveness. These findings emphasize the importance of host-related immune architecture and support further investigation of lymph node–based immune biomarkers in EAC.

Schlagwörter

Stichwörter der Autor:innen

MECAesophageal cancerhigh-endothelial venule (HEV)neoadjuvant treatmentprognosis

Autor:innen und Institutionen

  • Institute of Pathology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Center for Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany.
  • Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Department of General, Visceral and Cancer Surgery, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.

Zitieren

APA

Mirzaie-Kuzehgarani, A., Bedau, T., Teloh-Benger, J., Zander, T., Schlößer, H. A., Büttner, R., Bruns, C., & Quaas, A. (2026). Clinical and prognostic significance of high-endothelial venule density in regional lymph nodes of esophageal adenocarcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1802849

Vancouver

Mirzaie-Kuzehgarani A, Bedau T, Teloh-Benger J, Zander T, Schlößer HA, Büttner R, et al. Clinical and prognostic significance of high-endothelial venule density in regional lymph nodes of esophageal adenocarcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1802849

BibTeX
@article{MirzaieKuzehgarani2026,
  author = {Mirzaie-Kuzehgarani, Aryan and Bedau, Tillmann and Teloh-Benger, Johanna and Zander, Thomas and Schlößer, Hans Anton and Büttner, Reinhard and Bruns, Christiane and Quaas, Alexander},
  title = {Clinical and prognostic significance of high-endothelial venule density in regional lymph nodes of esophageal adenocarcinoma},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1802849}
}
Kostenlos starten →